参考文献:1. Colina F, Molero A, Cas谋s B, Mart谋nez-Montiel P. Infliximab-related hepatitis: a case study and literature review. / Dig Dis Sci. 2013;58:3362鈥?367. CrossRef 2. Ghabril M, Bonkovsky HL, Kum C, et al. Liver injury from tumor necrosis factor alpha antagonists: analysis of thirty-four cases. / Clin Gastroent Hepatol. 2013;11:558鈥?64. CrossRef 3. Tobon GJ, Ca帽as C, Jaller JJ, Restrepo JC, Anaya JM. Serious liver disease induced by infliximab. / Clin Rheumatol. 2007;26:578鈥?81. 4. Goujon C, Dahel K, B茅rard F, Guillot I, Gunera-Saad N. Autoimmune hepatitis in two psoriasis patients treated with infliximab. / J Am Acad Dermatol. 2010;63:43鈥?4. CrossRef 5. Bezabeh S, Flowers C, Kortepeter C, et al. Clinically significant liver injury in patients treated with natalizumab. / Aliment Pharmacol Ther. 2010;31:1028鈥?035. 6. Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. / J Hepatol. 2011;55:747鈥?49. CrossRef 7. Germano V, Picchianti A, Baccano G, et al. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. / Ann Rheum Dis.. 2005;64:1519鈥?520. CrossRef 8. Subramaniam K, Chitturi S, Brown M. Infliximab-induced autoimmune hepatitis in Crohn鈥檚 disease treated with budesonide and mycophenolate. / Inflamm Bowel Dis. 2011;17:E149鈥揈150. CrossRef
作者单位:Maurizio Bonacini (1) Marwan Ghabril (2) Herbert L. Bonkovsky (3)
1. California Pacific Medical Center, San Francisco, CA, USA 2. Indiana University, Indianapolis, IN, USA 3. Carolinas HealthCare System, Charlotte, NC, USA